Most Recent Annual Report
Upgrade your company profile to unlock all of your annual report content on AnnualReports.com
2019 Form 10K

Odonate Therapeutics, Inc. has reached its limit for free report views.
Work for Odonate Therapeutics, Inc.?
Claim Your ProfileUpgrade your company profile to unlock all of your annual report content on AnnualReports.com
Odonate Therapeutics, Inc. has reached its limit for free report views.
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer.